Unicycive Therapeutics Inc (UNCY)

Schlusskurs vom Vortag:

$1.12

Offen:

$1.15

24-Stunden-Volumen:

168.64K

Marktkapitalisierung:

$38.93M

Einnahmen:

-

Nettoeinkommen (Verlust:

$-30.54M

KGV:

-0.5657

EPS:

-1.98

Netto-Cashflow:

$-18.30M

1W Leistung:

+8.74%

1M Leistung:

-18.25%

6M Leistung:

+86.98%

1J Leistung:

-9.68%

1-Tages-Spanne:

$1.1097

$1.15

52-Wochen-Spanne:

$0.47

$1.8227

Unicycive Therapeutics Inc Stock (UNCY) Company Profile

Firmenname

Unicycive Therapeutics Inc

Sektor

Healthcare (1213)

Branche

Biotechnology (699)

Telefon

650 351 4495

Adresse

4300 El Camino Real, Suite 210, Los Altos

Mitarbeiter

9

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

UNCY's Discussions on Twitter

Unicycive Therapeutics Inc Aktie (UNCY) Neueste Nachrichten

Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference

GlobeNewswire Inc.

Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire Inc.

Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress

GlobeNewswire Inc.

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Unicycive Announces $50 Million Private Placement

GlobeNewswire Inc.

Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference

GlobeNewswire Inc.

Finanzdaten der Unicycive Therapeutics Inc-Aktie (UNCY)

Unicycive Therapeutics Inc (UNCY) Nettogewinn 2024

Unicycive Therapeutics Inc (UNCY) Free Cashflow 2024

Unicycive Therapeutics Inc (UNCY) Gewinn je Aktie 2024